James C. Kisicki

970 total citations
28 papers, 789 citations indexed

About

James C. Kisicki is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, James C. Kisicki has authored 28 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Epidemiology. Recurrent topics in James C. Kisicki's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Pain Management and Opioid Use (3 papers) and Pneumonia and Respiratory Infections (3 papers). James C. Kisicki is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Pain Management and Opioid Use (3 papers) and Pneumonia and Respiratory Infections (3 papers). James C. Kisicki collaborates with scholars based in United States, Switzerland and United Kingdom. James C. Kisicki's co-authors include R Baughman, Cynthia Mattia‐Goldberg, Garret A. FitzGerald, Shiv Kapoor, Rajesh Agarwal, Robert J. Przybelski, Francesca Catella-Lawson, Elaine K. Daily, Wayne A. Colburn and J Rasmussen and has published in prestigious journals such as Circulation, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

James C. Kisicki

27 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Kisicki United States 17 166 146 116 107 90 28 789
T D Bjornsson United States 16 158 1.0× 159 1.1× 50 0.4× 122 1.1× 67 0.7× 23 979
Yoshinori Horie Japan 21 223 1.3× 447 3.1× 51 0.4× 100 0.9× 153 1.7× 86 1.6k
R Dzúrik Slovakia 15 86 0.5× 157 1.1× 52 0.4× 56 0.5× 147 1.6× 113 828
David Harry United Kingdom 12 232 1.4× 166 1.1× 50 0.4× 23 0.2× 170 1.9× 25 896
Nada Majkić‐Singh Serbia 16 104 0.6× 185 1.3× 28 0.2× 45 0.4× 138 1.5× 130 1.0k
Kentaro Oniki Japan 20 114 0.7× 227 1.6× 42 0.4× 67 0.6× 98 1.1× 87 1.1k
Chen Shapira Israel 15 236 1.4× 137 0.9× 198 1.7× 41 0.4× 106 1.2× 26 978
Paul F. Gulyassy United States 17 127 0.8× 253 1.7× 109 0.9× 48 0.4× 124 1.4× 36 802
N. R. Peden United Kingdom 15 191 1.2× 93 0.6× 57 0.5× 87 0.8× 127 1.4× 31 653
Junji Saruwatari Japan 22 119 0.7× 259 1.8× 38 0.3× 127 1.2× 139 1.5× 108 1.4k

Countries citing papers authored by James C. Kisicki

Since Specialization
Citations

This map shows the geographic impact of James C. Kisicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Kisicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Kisicki more than expected).

Fields of papers citing papers by James C. Kisicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Kisicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Kisicki. The network helps show where James C. Kisicki may publish in the future.

Co-authorship network of co-authors of James C. Kisicki

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Kisicki. A scholar is included among the top collaborators of James C. Kisicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Kisicki. James C. Kisicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Franklin K., et al.. (2011). Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules. The Journal of Clinical Pharmacology. 52(5). 747–756. 25 indexed citations
2.
3.
Brown, Karen, Joseph R. Walker, Robert J. Noveck, et al.. (2009). Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide. The Journal of Clinical Pharmacology. 50(5). 554–565. 22 indexed citations
4.
Wang, Yanfeng, Ophelia Yin, Peter Gräf, James C. Kisicki, & Horst Schran. (2008). Dose‐ and Time‐Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus. The Journal of Clinical Pharmacology. 48(6). 763–775. 40 indexed citations
5.
Krishna, Gopal, James C. Kisicki, Steven Olsen, Dennis M. Grasela, & Zaiqi Wang. (2007). The Effect of Omeprazole on the Bioavailability and Safety of Garenoxacin in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(5). 628–632. 1 indexed citations
6.
7.
Becker, Michael A., James C. Kisicki, Reza Khosravan, et al.. (2004). Febuxostat (TMX‐67), a Novel, Non‐Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1111–1116. 76 indexed citations
8.
Kern, Steven E., et al.. (2003). A Pharmacokinetic Study to Compare Two Simultaneous 400 μg Doses with a Single 800 μg Dose of Oral Transmucosal Fentanyl Citrate. Journal of Pain and Symptom Management. 26(2). 743–747. 22 indexed citations
9.
Kovarik, John M., et al.. (2002). Administration diluents differentiate Neoral from a generic cyclosporine oral solution. Clinical Transplantation. 16(4). 306–309. 8 indexed citations
10.
Viegas, Tacey X., George Omura, R Stoltz, & James C. Kisicki. (2000). Pharmacokinetics and Pharmacodynamics of Peldesine (BCX‐34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers. The Journal of Clinical Pharmacology. 40(4). 410–420. 29 indexed citations
11.
Baughman, R, Shiv Kapoor, Rajesh Agarwal, et al.. (1998). Oral Delivery of Anticoagulant Doses of Heparin. Circulation. 98(16). 1610–1615. 110 indexed citations
12.
Kisicki, James C., et al.. (1998). Effect of Increasing Gastric pH with Famotidine on the Absorption and Oral Pharmacokinetics of the Inotropic Agent Vesnarinone. The Journal of Clinical Pharmacology. 38(5). 429–432. 5 indexed citations
13.
14.
Przybelski, Robert J., et al.. (1996). Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Critical Care Medicine. 24(12). 1993–2000. 104 indexed citations
15.
Harrison, Lester I., et al.. (1994). Comparative Pharmacokinetics of Morning and Evening Doses of Once-a-Day Theophylline Capsules. Journal of Pharmaceutical Sciences. 83(8). 1171–1174. 3 indexed citations
16.
Dixon, Ross, et al.. (1993). Acadesine (AICA‐Riboside): Disposition and Metabolism of an Adenosine‐Regulating Agent. The Journal of Clinical Pharmacology. 33(10). 955–958. 17 indexed citations
17.
Harrison, Lester I., Amit Mitra, Sally McCarville, et al.. (1993). Kinetics of Absorption of a New Once-a-Day Formulation of Theophylline in the Presence and Absence of Food. Journal of Pharmaceutical Sciences. 82(6). 644–648. 7 indexed citations
18.
Cerimele, Benito J., et al.. (1992). Pharmacokinetics of cefaclor AF: effects of age, antacids and H2-receptor antagonists.. PubMed. 68 Suppl 3. S3–9. 11 indexed citations
19.
Kisicki, James C., et al.. (1992). The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis & Rheumatism. 35(7). 761–764. 29 indexed citations
20.
Bannister, S J, Vincent P. Houser, James D. Hulse, James C. Kisicki, & J Rasmussen. (1989). Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin. Acta Psychiatrica Scandinavica. 80(S350). 102–106. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T D Bjornsson Breakdown of academic impact, for papers by Yoshinori Horie Breakdown of academic impact, for papers by R Dzúrik Breakdown of academic impact, for papers by David Harry Breakdown of academic impact, for papers by Nada Majkić‐Singh Breakdown of academic impact, for papers by Kentaro Oniki Breakdown of academic impact, for papers by Chen Shapira Breakdown of academic impact, for papers by Paul F. Gulyassy Breakdown of academic impact, for papers by N. R. Peden Breakdown of academic impact, for papers by Junji Saruwatari
Rankless by CCL
2026